Status:
TERMINATED
The Effect of Enoxaparin Sodium on the Incidence of Deep Vein Thrombosis Following Electrophysiology Studies and Radiofrequency Ablation.
Lead Sponsor:
Melbourne Health
Collaborating Sponsors:
Sanofi
National Heart Foundation, Australia
Conditions:
Deep Vein Thrombosis
Eligibility:
All Genders
18-80 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to assess the effect of the anticoagulant(blood thinner) Clexane on the development of leg clots following electrophysiology studies (EPS) and or radiofrequency ablation (...
Eligibility Criteria
Inclusion
- Patients undergoing EPS/RFA for the diagnosis and or treatment of SVT based on patient history or ECG evidence.
Exclusion
- Patients with a past history of DVT or PE.
- Patients with a history of clotting disorders
- Patients with active malignancies
- Patients requiring full heparinisation during and after the procedure.
- Chronic atrial flutter and atrial fibrillation ablation
Key Trial Info
Start Date :
August 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2011
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT00232271
Start Date
August 1 2005
End Date
February 1 2011
Last Update
May 30 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Royal Melbourne hospital
Melbourne, Victoria, Australia, 3050